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Background/Objective: Psoriasis, a disturbing dermatological disorder, often results in ongoing disease
and disability. However, relatively little has been published quantifying the quality of life (QoL) of pa-
tients with psoriasis in Taiwan. This study was conducted to investigate the impact of psoriasis on the
QoL of patients and to explore determinant factors.
Methods: A total of 200 patients, 100 patients with psoriasis and 100 patients with general skin diseases,
were asked to fulﬁll a QoL questionnaire modiﬁed from Skindex-16 to include an additional ﬁve items
pertaining to occupational impact. The clinical data were collected and the severity of psoriasis was
evaluated with the Psoriasis Area and Severity Index score. The data were examined to ascertain factors
that impact the QoL in patients with psoriasis.
Results: Compared with patients with common skin disorders, patients with psoriasis experienced a
deterioration of their QoL in the aspects of symptoms, emotions, daily life function and occupational
scales. After further analysis, we noted that neither the severity of disease, duration of disease, age of
patients, sex, educational level of patients, nor family history is the determinant factor that worsens their
QoL. Instead, the site of the lesions, especially those on exposed areas including hand and facial
involvement, has a tremendous impact on their QoL.
Conclusion: Psoriasis has an appreciable effect on QoL, especially when it affects the hands and face. Of
the four scales included in our study, the daily life function and occupational scales revealed the greatest
effect. The sense of stigma may be the key factor that results in this outcome. To improve the QoL and
therapeutic effects, a team needs to be constructed which includes dermatologists, psychologists, social
workers, and help from the government is needed to accomplish the task.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Several skin disorders can affect quality of life (QoL).1 Skin disease
results in strong negative emotions, annoying symptoms, and the
lack of social and occupational abilities. The skin not only provides
thermal and physical protection, but also represents our physical
appearance; defective skin often results in low self-esteem.2 The
effects of different skin diseases on patients vary and are not always
directly proportional to the severity of the disease.3 The extent to
which skin diseases affect the QoL of patients depends on manyy have no ﬁnancial or non-
atter or materials discussed
gy, Changhua Christian Hos-
ounty 500, Taiwan.
cal Association. Published by Elsevfactors such as the nature of the disease, the duration of the disease,
and the site of involvement. Over the past decade, issues related to
the QoL of patients with skin diseases are gradually being taken
more seriously, and scholars have tried to use various methods to
evaluate QoL.4e7
Psoriasis is not a rare skin disease, with a prevalence of
approximately 1e2% in Caucasians and a lower prevalence in
Mongolians.8 Its pathogenesis and progression are not only related
to genetic reason, but also emotional stress, drugs, infections, and
physical trauma. In addition, conditions such as inﬂammatory
bowel disease and arthritis are related complications of psoriasis.
Therefore, this disease may result in poor appearance and impair
daily life functions. Furthermore, it cannot be completely cured,
which often leads to psychological distress in patients. Emotional
stress may also lead to the deterioration of clinical symptoms in
patients with psoriasis. Therefore, a vicious cycle is formed, which
not only increases stress in patients, but also negatively affects theier Taiwan LLC. All rights reserved.
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the QoL of patients with psoriasis in Taiwan is not well studied. This
aims of this study are to understand the degree of inﬂuence of
emotional factors on the QoL of patients with psoriasis in Taiwan
and to enable dermatologists provide better comprehensive med-
ical care to patients.
Patients and methods
FromMarch 2004 to June 2004, data for 100 patients with psoriasis
(mean age 49.5 ± 15.9 years, and mean duration of disease
10.0 ± 9.3 years) and 100 patients with general skin diseases (mean
age 28.1 ± 14.9 years, and mean duration of disease 5.4 ± 8.0 years)
who were hospitalized or were outpatients at the Department of
Dermatology of Changhua Christian Hospital were randomly
selected. General skin diseases were deﬁned as all skin diseases
except psoriasis, such as allergy, folliculitis, urticaria, and eczema.
All patients agreed to participate in the project and signed an
informed consent after the investigators explained the purposes of
this study. A total of 200 patients received oral questionnaires
which were carried out in Chinese by an interviewer. The inter-
viewer was a dermatologist with a good knowledge of both English
and Chinese. The QoL of all included patients was assessed on the
basis of these data. The collected data included general personal
data as well as detailed records of family history, work patterns, site
of involvement, and complications. The severity of psoriasis was
quantitatively assessed by physicians using the Psoriasis Area and
Severity Index (PASI). With regard to QoL assessment, Skindex-16,
which is a reliable QoL scale for skin disease patients, was used.4
Patients have to respond to 16 subscales initially; these are
further subdivided into three dimensions of symptoms, emotions,
and life and social functions. In this study, we added occupational
function as a fourth dimension; therefore, the questionnaire
eventually comprised 21 questions (Table S1). Each question
relating to QoL required patients to rate the degree of irritation felt
during the past month on a scale of 0 (never bothered) to 100
(always bothered). The higher the score, the more the quality of life
is impaired. The scale score is themean of the patients' responses to
the items in the given scale.
Patient data were recorded in Microsoft Excel sheets (Microsoft
Corp, Seattle, WA, USA) and analyzed using SPSS 15.0 statistical
software (SPSS, Inc., Chicago, IL, USA). The level of statistical sig-
niﬁcance was set at 5%.
During evaluation of the QoL of patients, the characteristics of
each set of data were considered and various statistical methods
were used. For the comparison of continuous variables between
samples according to a nonparametric hypothesis and in situations
with nonnormal distribution or a small sample size, the Mann-
Whitney U test was used for two independent samples and the
Jonckheere-Terpstra test was used to test for ordered differences
among classes.
Results
The patients with psoriasis reported severe interference in all as-
pects of their lives compared with the patients with general skin
diseases. The degree of deterioration in the QoL of patients was
statistically signiﬁcant in terms of all the four dimensions
(p < 0.001; Table 1), namely symptoms (psoriasis: control group
37.0:21.9), emotions (62.6:40.2), life and social functions
(42.1:16.6), and occupational function (24.3:5.0). The PASI scores of
patients were analyzed to understand the correlation between QoL
deterioration and clinical symptom severity; no correlation was
observed (Table 1). With regard to the duration of disease, QoL
deterioration was unrelated to symptoms, emotions, life and socialfunctions, or occupational function. There were no age-related
differences in the degree of inﬂuence on QoL (Table 2).
With regard to sex, the degree of inﬂuence of symptoms was
slightly higher in women than in men (43.3 vs. 34.6); the same
trend was observed for the emotions dimension (63.7 vs. 62.2). The
opposite was true for the dimensions of life and social functions
(women 41.1 vs. men 42.4) and occupational function (women 18.7
vs. men 26.4). However, none of the differences were statistically
signiﬁcant, indicating that sex is not a signiﬁcant factor affecting
the QoL of patients with psoriasis (Table 3).
To evaluate the inﬂuence of education on the QoL, the patients
were divided into a group that had received an education of high
school level or below and a group that had received education at
college level or higher. This was done to analyze whether education
inﬂuences patient acceptance of the disease, QoL improvement,
and the ability to receive and search information relating to the
disease. The result showed no inﬂuence of education on QoL
deterioration (Table 4). Similarly, family history of psoriasis had no
inﬂuence on QoL deterioration (Table 5).
However, patients with disease involving their handsweremore
depressed (59.1:26.9) and more severely affected in terms of life
and social functions (45.3:13.4) and occupational function
(27.2:4.0) compared with those with general skin diseases
involving their hands (Table 6). Furthermore, although therewas no
signiﬁcant difference between patients with general skin diseases
and those with psoriasis in terms of symptom severity (38.9:30.6),
patients with psoriasis involving their hands worried more about
losing their job (29.0) compared with patients with other skin
diseases involving their hands (8.5). For psoriasis patients alone,
patients with hand involvement were also more depressed
(22.8:59.1) and more affected in terms of life and social functions
(27.2:45.3) and occupational function (11.0:27.2) compared with
those without hand involvement (Table 7).
In the analysis of the inﬂuence of disease involving the face, the
inﬂuence on emotions was higher in patients with facial involve-
ment than in those without (37.2:23.0) in both groups. Further-
more, the patients with psoriasis involving the face were more
severely affected than those with general skin diseases involving
the face in terms of life and social functions (43.8:15.6) and occu-
pational function (26.9:2.2; Table 8). Taken together, and consid-
ering that there is no correlation between QoL and PASI score, the
above results indicate that the QoL of patients with psoriasis is
more severely affected by the site of involvement, particularly the
face and hands, because they generally remain exposed, and not the
extent of disease or inﬂammation. The QoL of patients with hand
and face involvement was severely affected, particularly in terms of
life, social, and occupational functions, even though there was no
signiﬁcant difference in objective PASI score and subjective symp-
tom severity in these patients.
Discussion
For several years, scholars have agreed that there is a correlation
between the development and progression of psoriasis and
emotional stress. Furthermore, Hall et al9 reported that psycho-
logical stress may be an important precursor of psoriasis. Gupta
et al10 reported that patients with psoriasis experienced signiﬁcant
emotional deterioration and that more than 5% of patients suffer
from depression and have suicidal intentions. Seville11e13 and
Devrimci-Ozguven14 reported that patients with psoriasis experi-
enced much more severe psychological and emotional stress. In
another study on psoriasis, patients believed that their symptoms
affected their daily life and emotions; this depression resulted in a
vicious cycle and eventually resulted in the worsening of symp-
toms.15 This emotional stress also inﬂuences the performance of
Table 1 The results of Skindex-16 and the relationship with severity and QoL.
Control (n ¼ 100) Psoriasis (n ¼ 100) pb
Mean Median (range) Mean Median (range) PASI
Ra p
Age 28.1 22.4 (3.0e82.4) 49.5 49.7 (12.6e79.0) 0.183 0.072 <0.001
PASI score 11.5 7.9 (0.4e43.7)
Duration of disease 5.4 2.5 (0.0e45.0) 10.0 6.8 (0.0e42.0) 0.032 0.753 <0.001
Symptoms scale 21.9 13.8 (0.0e97.3) 37.0 35.0 (0.0e90.0) 0.198 0.051 <0.001
Itching 36.2 25.0 (0.0e100.0) 53.2 50.0 (0.0e100.0) 0.017 0.869 <0.001
Burning/stinging 14.0 0.0 (0.0e100.0) 30.4 20.0 (0.0e100.0) 0.258 0.011 <0.001
Hurting 10.9 0.0 (0.0e95.0) 26.3 10.0 (0.0e100.0) 0.220 0.031 <0.001
Irritated 26.7 10.0 (0.0e100.0) 38.3 40.0 (0.0e100.0) 0.123 0.231 0.023
Emotions scale 40.2 40.7 (0.0e99.3) 62.6 64.3 (0.0e100.0) 0.179 0.080 <0.001
Persistence/recurrence 42.5 40.0 (0.0e100.0) 70.0 80.0 (0.0e100.0) 0.050 0.630 <0.001
Worry 55.9 70.0 (0.0e100.0) 72.6 95.0 (0.0e100.0) 0.027 0.790 <0.001
Appearance 52.5 50.0 (0.0e100.0) 70.3 90.0 (0.0e100.0) 0.047 0.647 <0.001
Frustration 36.0 30.0 (0.0e100.0) 57.4 50.0 (0.0e100.0) 0.230 0.023 <0.001
Embarrassment 38.1 30.0 (0.0e100.0) 61.5 60.0 (0.0e100.0) 0.181 0.077 <0.001
Annoyed 28.9 10.0 (0.0e100.0) 53.9 50.0 (0.0e100.0) 0.189 0.064 <0.001
Depressed 27.3 10.0 (0.0e100.0) 52.6 50.0 (0.0e100.0) 0.214 0.036 <0.001
Functioning scale 16.6 8.0 (0.0e96.0) 42.1 40.0 (0.0e100.0) 0.149 0.144 <0.001
Interactions with others 20.3 0.0 (0.0e100.0) 48.7 50.0 (0.0e100.0) 0.103 0.318 <0.001
Desire to be with people 10.9 0.0 (0.0e100.0) 39.3 40.0 (0.0e100.0) 0.243 0.016 <0.001
Show affection 8.1 0.0 (0.0e90.0) 36.0 50.0 (0.0e100.0) 0.123 0.231 <0.001
Daily activities 23.0 7.5 (0.0e100.0) 41.9 50.0 (0.0e100.0) 0.034 0.742 <0.001
Work/What you enjoy 21.0 0.0 (0.0e100.0) 44.4 50.0 (0.0e100.0) 0.088 0.390 <0.001
Occupational scale 5.0 0.0 (0.0e94.0) 24.3 10.0 (0.0e100.0) 0.165 0.107 <0.001
May need to leave job 6.6 0.0 (0.0e100.0) 26.6 0.0 (0.0e100.0) 0.142 0.165 <0.001
Fear of being ﬁred 4.7 0.0 (0.0e100.0) 20.5 0.0 (0.0e100.0) 0.058 0.571 <0.001
Financial future 4.1 0.0 (0.0e80.0) 26.1 0.0 (0.0e100.0) 0.146 0.153 <0.001
Interactions with co-workers 4.6 0.0 (0.0e90.0) 26.3 0.0 (0.0e100.0) 0.150 0.141 <0.001
Difﬁculty using hands 5.1 0.0 (0.0e100.0) 21.9 0.0 (0.0e100.0) 0.207 0.042 <0.001
N ¼ number of patients; SD ¼ standard deviation.
a Pearson Correlation Coefﬁcient
b p value by Mann-Whitney U test.
Table 2 Correlation of QoL with age in patients with psoriasis.
Age pa
<20 (n ¼ 3) 20e39 (n ¼ 25) 40e59 (n ¼ 41) 60e79 (n ¼ 31) Total (n ¼ 100)
Mean Median (range) Mean Median (range) Mean Median (range) Mean Median (range) Mean Median (range)
Symptoms scale 19.2 16.9 (12.6e17.7) 37.7 31.2 (21.8e39.9) 39.9 49.0 (40.0e59.3) 34.4 66.9 (60.0e79) 37.0 49.7 (12.6e79.0) 0.706
Emotions scale 64.3 20.0 (12.5e25.0) 70.5 42.5 (2.5e70.0) 63.2 35.0 (2.5e87.5) 55.3 27.5 (0.0e90.0) 62.6 35.0 (0.0e90.0) 0.028
Functioning scale 12.7 64.3 (50.0e78.6) 45.7 82.9 (0.0e100.0) 42.9 64.3 (1.4e100.0) 40.8 58.6 (2.9e97.1) 42.1 64.3 (0.0e100.0) > 0.99
Occupational scale 23.3 10.0 (0.0e28.0) 23.0 40.0 (4.0e96.0) 27.4 40.0 (0.0e100.0) 21.2 48.0 (0..0e100.0) 24.3 40.0 (0.0e100.0) 0.452
a The p values were obtained using the Jonckheere-Terpstra test.
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considerable knowledge about the different degrees of emotions
experienced by each individual patient and the associated factors in
order to provide the most appropriate treatment.
In this study, the QoL of patients in all aspects of daily life was
more severely affected in patients with psoriasis than in those with
general skin diseases. However, there was no correlation betweenTable 3 Correlation of QoL with sex in patients with psoriasis.
Sex pa
Male (n ¼ 72) Female (n ¼ 28)
Mean Median (range) Mean Median (range)
Symptoms scale 34.6 29.4 (0.0e87.5) 43.3 45.0 (5.0e90.0) 0.063
Emotions scale 62.2 63.6 (2.9e100.0) 63.7 68.6 (0.0e100.0) 0.645
Functioning scale 42.2 40.0 (0.0e100.0) 41.1 35.0 (0.0e100.0) 0.854
Occupational scale 26.4 10.0 (0.0e100.0) 18.7 4.0 (0.0e74.0) 0.283
a The p values were obtained using the Mann-Whitney U test.clinical symptom severity and the extent of QoL deterioration,
which was consistent with the ﬁndings of Fortune et al.15
Furthermore, disease duration was not correlated with QoL dete-
rioration in terms of symptoms, emotions, life and social functions,
and occupational function, a ﬁnding consistent with that of Akay
et al.17 We also found that age had no inﬂuence on the degree of
QoL deterioration. These ﬁndings indicate that after the onset ofTable 4 Correlation of QoL with educational level in patients with psoriasis.
Education pa
High school level or
below (n ¼ 82)
College level or higher
(n ¼ 18)
Mean Median (range) Mean Median (range)
Symptoms scale 37.2 36.3 (0.0e90.0) 36.1 31.3 (7.5e86.3) 0.893
Emotions scale 62.6 64.3 (0.0e100.0) 62.9 68.6 (25.7e97.1) 0.858
Functioning scale 42.4 40.0 (0.0e100.0) 40.7 32.0 (0.0e88.0) 0.833
Occupational scale 25.3 10.0 (0.0e100.0) 19.4 7.0 (0.0e100.0) 0.582
a The p values were obtained using the Mann-Whitney U test.
Table 5 Correlation of QoL with family history in patients with psoriasis.
Family history of psoriasis pa
No (n ¼ 84) Yes (n ¼ 16)
Mean Median (range) Mean Median (range)
Age 50.7 50.5 (12.6e79.0) 43.3 43.4 (16.9e65.1) 0.096
PASI score 11.2 7.8 (0.8e43.7) 13.1 9.5 (0.4e42.4) 0.697
Duration of disease (y) 10.0 6.3 (0.0e42.0) 10.0 10.0 (0.0e25.0) 0.500
Symptoms scale 36.2 33.8 (0.0e90.0) 41.2 40.0 (2.5e77.5) 0.392
Emotions scale 62.1 64.3 (0.0e100.0) 65.4 72.9 (14.3e98.6) 0.550
Functioning scale 42.4 40.0 (0.0e100.0) 40.5 35.0 (0.0e100.0) 0.735
Occupational scale 24.0 8.0 (0.0e100.0) 25.6 15.0 (0.0e100.0) 0.522
a The p values were obtained using the Mann-Whitney U test.
Table 7 Comparison of QoL in psoriasis patients with and without hand
involvement.
Psoriasis Hand involvement pa
No (n ¼ 18) Yes (n ¼ 82)
Mean Median (range) Mean Median (range)
Age 54.1 54.7 (17.7e76.0) 48.5 47.6 (12.6e79.0) 0.118
PASI score 7.9 5.3 (1.0e30.4) 12.4 9.0 (0.4e43.7) 0.024
Duration of disease 11.3 4.8 (0.0e40.0) 9.7 7.0 (0.0e42.0) 0.568
Symptoms scale 28.3 22.5 (5.0e86.3) 38.9 38.8 (0.0e90.0) 0.077
Itching 53.6 50.0 (0.0e100.0) 53.0 50.0 (0.0e100.0) 0.945
Burning/stinging 18.3 0.0 (0.0e100.0) 33.0 30.0 (0.0e100.0) 0.052
Hurting 12.2 0.0 (0.0e80.0) 29.3 20.0 (0.0e100.0) 0.024
Irritated 28.9 5.0 (0.0e100.0) 40.4 45.0 (0.0e100.0) 0.185
Emotions scale 53.4 50.7 (2.9e97.1) 64.6 67.9 (0.0e100.0) 0.102
Persistence/recurrence 73.3 85.0 (0.0e100.0) 69.3 80.0 (0.0e100.0) 0.439
Worry 71.7 100.0 (0.0e100.0) 72.8 90.0 (0.0e100.0) 0.882
Appearance 68.3 90.0 (0.0e100.0) 70.7 90.0 (0.0e100.0) 0.981
Frustration 39.4 50.0 (0.0e100.0) 61.3 70.0 (0.0e100.0) 0.017
Embarrassment 53.8 50.0 (0.0e100.0) 63.2 65.0 (0.0e100.0) 0.424
Annoyed 44.4 50.0 (0.0e100.0) 56.0 50.0 (0.0e100.0) 0.208
Depressed 22.8 0.0 (0.0e100.0) 59.1 50.0 (0.0e100.0) 0.000
Functioning scale 27.2 20.0 (0.0e74.0) 45.3 44.0 (0.0e100.0) 0.018
Interactions with
others
30.6 10.0 (0.0e100.0) 52.7 50.0 (0.0e100.0) 0.050
Desire to be with
people
17.8 0.0 (0.0e70.0) 44.0 50.0 (0.0e100.0) 0.009
Show affection 24.4 10.0 (0.0e100.0) 38.5 50.0 (0.0e100.0) 0.181
Daily activities 25.0 5.0 (0.0e80.0) 45.6 50.0 (0.0e100.0) 0.032
Work/What you enjoy 38.3 40.0 (0.0e100.0) 45.7 50.0 (0.0e100.0) 0.468
Occupational scale 11.0 0.0 (0.0e64.0) 27.2 17.0 (0.0e100.0) 0.024
May need to leave job 15.6 0.0 (0.0e80.0) 29.0 0.0 (0.0e100.0) 0.243
Fear of being ﬁred 6.7 0.0 (0.0e70.0) 23.5 0.0 (0.0e100.0) 0.044
Financial future 15.0 0.0 (0.0e70.0) 28.5 0.0 (0.0e100.0) 0.144
Interactions with co-
workers
11.7 0.0 (0.0e70.0) 29.5 5.0 (0.0e100.0) 0.060
Difﬁculty using hands 6.1 0.0 (0.0e50.0) 25.4 0.0 (0.0e100.0) 0.039
a The p values were obtained using the Mann-Whitney U test.
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pects; progression or amelioration of the disease will not be
inﬂuenced by age or disease duration. They also indicate that pa-
tients suffer from considerable psychological pressure from disease
onset and that their treatment process does not include any mea-
sures to relieve this stress. Education level, sex, and family history
also did not exhibit any correlation with QoL deterioration, indi-
cating the lack of relevant education, psychological counseling, and
social assistance from medical and social resources in Taiwan. The
QoL of patients thus remains poor because of the lack of subjective
resources, although objective measures such as the provision of
external information, self-psychological adjustments, and family
counseling are provided.
The site of involvement was found to be a signiﬁcant factor
inﬂuencing QoL deterioration, particularly in patients with disease
involving routinely exposed parts that cannot be covered, such as
the face and hands. Ginsburg et al18 reported that patients with
psoriasis tend to consider their disease as a social stigma, are more
sensitive, often think that that they have ﬂaws, feel shameful,
guilty, and isolated, and shy away from participation in group ac-
tivities.19 This theory is supported by our research results. In the
study by Kadyk et al20 on the QoL in patients with allergic contact
dermatitis, patients with atopic dermatitis, comparedwith patients
without atopic dermatitis, patients with atopy had a better QoL.
Although they had more severe symptoms or allergies in other
body parts or systems, they were signiﬁcantly less worried about
losing jobs because of hand disease. This is because atopic
dermatitis is widely recognized by the general public, because the
relevant medical and health education resources are very rich, and
because patients as well as normal individuals have a considerable
degree of knowledge and recognition of this disease. Therefore,Table 6 Comparison of QoL with hand involvement between the psoriatic and the
control groups.
Hand involvement pa
Control (n ¼ 26) Psoriasis (n ¼ 82)
Mean Median (range) Mean Median (range)
Symptoms scale 30.6 25.0 (0.0e97.3) 38.9 38.8 (0.0e90.0) 0.095
Hurting 18.3 0.0 (0.0e95.0) 29.3 20.0 (0.0e100.0) 0.051
Emotions scale 38.5 44.3 (0.0e99.3) 64.6 67.9 (0.0e100.0) <0.001
Frustration 30.6 15.0 (0.0e100.0) 61.3 70.0 (0.0e100.0) <0.001
Depressed 26.9 5.0 (0.0e100.0) 59.1 50.0 (0.0e100.0) <0.001
Functioning scale 13.4 11.0 (0.0e44.0) 45.3 44.0 (0.0e100.0) <0.001
Desire to be with
people
3.1 0.0 (0.0e50.0) 44.0 50.0 (0.0e100.0) <0.001
Daily activities 28.5 15.0 (0.0e90.0) 45.6 50.0 (0.0e100.0) 0.047
Occupational scale 4.0 0.0 (0.0e26.0) 27.2 17.0 (0.0e100.0) <0.001
May need to leave job 8.5 0.0 (0.0e100.0) 29.0 0.0 (0.0e100.0) 0.008
Fear of being ﬁred 0.0 0.0 (0.0e0.0) 23.5 0.0 (0.0e100.0) 0.001
Difﬁculty using hands 7.7 0.0 (0.0e50.0) 25.4 0.0 (0.0e100.0) 0.030
a The p values were obtained using the Mann-Whitney U test.patients with atopic dermatitis accept their illness more easily and
can explain their situation to others; this ameliorates anxiety and
the feeling of being a social stigma and isolation from society and
results in a better QoL. On the other hand, patients with psoriasis
continuously feel frustrated and have a poor QoL because of the
signiﬁcant lack of relevant medical and health education resources
available to them, their families, and the general public. Therefore,
measures to strengthen the relevant medical and health education
resources should be implemented to resolve the current situation.
The main limitation of this study is that the Chinese version of
the questionnaire adopted in this study has not been proved as a
reliable and valid measure of skin disease on the quality of life in
Taiwanese/Chinese patients. Nonetheless, the interviewer whowas
a dermatologist proﬁcient in Chinese and English did his best ef-
forts to explain in detail the contents of the questionnaire during
the interview process to assist the patients in understanding and
ﬁlling out the questionnaires. Besides, the He et al study shows thatTable 8 Comparison of QoL with face involvement between the psoriatic and the
control groups.
Face involvement pa
Control (n ¼ 49) Psoriasis (n ¼ 79)
Mean Median (range) Mean Median (range)
Symptoms scale 23.0 15.0 (0.0e97.3) 37.2 37.5 (0.0e87.5) <0.001
Emotions scale 44.0 45.7 (0.0e99.3) 66.1 68.6 (0.0e100.0) <0.001
Functioning scale 15.6 8.0 (0.0e70.0) 43.8 40.0 (0.0e100.0) <0.001
Occupational scale 2.2 0.0 (0.0e28.0) 26.9 14.0 (0.0e100.0) <0.001
a The p values were obtained using the Mann-Whitney U test.
H.-J. Yang, K.-C. Yang / Dermatologica Sinica 33 (2015) 146e150150the Skindex-16 questionnaire is suitable for measuring the quality
of life in Chinese patients with skin diseases.21
Conclusion
Psoriasis has been proved to be an emotional stress-related illness.
There is a close relationship between the disease and stress, which
results in a vicious cycle. This means that psoriasis will be induced
by emotional stress, which in turn will cause further deterioration
of symptoms and poor treatment outcomes. To achieve the ideal
treatment outcome, it is important to understand the factors that
emotionally disturb the patient and provide measures to relieve
these emotions. In this study, a key factor that affected the QoL of
patients was the site of involvement, particularly the face and
hands because they cannot be covered, and not the severity or
duration of disease, age, sex, family history, or education level. The
proportion of patients that are frustrated, afraid to interact with
others, and extremely worried about losing their job because of
their disease has seen a dramatic increase, probably because the
management of these patients focuses only on pharmacological
therapy and does not include self-understanding and psychological
counseling. No relief or sense of security is provided by the social
welfare department, and no health education is provided by social
education units to the general public. All these factors result in
patient isolation and poor QoL. To achieve better clinical treatment
outcomes and enable all patients to receive treatment that will
beneﬁt them in all aspects and lead a satisfactory life, a multidis-
ciplinary approach by dermatologists, psychiatrists, social workers,
social education units, and medical teams of government welfare
departments is required.
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